Clinical Trial Update: Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating green tea extract for prevention of cervical cancer in patients with HPV infection and low-grade cervical intraepithelial neoplasia has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 1 | Phase 2 | Status: COMPLETED | Results posted: 2012-08-17